InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Browse the full record of transactions filed by Kayitalire Louis, Directeur Médical. Insider active across 1 companies, notably F-star Therapeutics, Inc.. In total, 8 disclosures have been logged. Total volume traded: €16k. The latest transaction was disclosed on 2 November 2021 (Cession). Regulator: SEC (Form 4). All data is free.
Declarations8 total
€22939 shares@ €5.87092.8% of flow
Common Stock
SEC:0001209191-21-063046·
€22939 shares@ €5.87091.4% of flow
Common Stock
SEC:0001209191-21-063046:0·
€39864 shares@ €6.21914.9% of flow
Common Stock
SEC:0001209191-21-059842·
€39864 shares@ €6.21912.4% of flow
Common Stock
SEC:0001209191-21-059842:0·
026,437 shares0
Common Stock
SEC:0001209191-21-053224·
026,437 shares0
Common Stock
SEC:0001209191-21-053224:0·
€7,5001,054 shares@ €7.116292.3% of flow
Common Stock
SEC:0001209191-21-045957·
€7,5001,054 shares@ €7.116246.1% of flow
Common Stock
SEC:0001209191-21-045957:0·
8 of 8 declarations
About Kayitalire Louis
Kayitalire Louis serves as the Chief Medical Officer at F-star Therapeutics, Inc. In this role, he is responsible for leading the company's medical and research initiatives. Louis oversees clinical programs and ensures that quality and safety standards are met in the development of treatments. His medical expertise is essential for innovation and the success of F-star Therapeutics.
